Abstract:ENPP1 expression correlates with poor prognosis in many cancers, and we previously discovered that ENPP1 is the dominant hydrolase of extracellular cGAMP: a cancer-cell-produced immunotransmitter that activates the anticancer STING pathway. However, ENPP1 has other catalytic activities and the molecular and cellular mechanisms contributing to its tumorigenic effects remain unclear. Here, using single cell RNA-seq (scRNA-seq), we show that ENPP1 overexpression drives primary breast tumor growth and metastasis by synergistically dampening extracellular cGAMP-STING mediated antitumoral immunity and activating immunosuppressive extracellular adenosine (eADO) signaling. In addition to cancer cells, stromal and immune cells in the tumor microenvironment (TME) also express ENPP1 that restrains their response to tumor-derived cGAMP. Enpp1 loss-of-function in both cancer cells and normal tissues slowed primary tumor initiation and growth and prevented metastasis in an extracellular cGAMP- and STING-dependent manner. Selectively abolishing the cGAMP hydrolysis activity of ENPP1 phenocopied total ENPP1 knockout, demonstrating that restoration of paracrine cGAMP-STING signaling is the dominant anti-cancer mechanism of ENPP1 inhibition. Strikingly, we find that breast cancer patients with low ENPP1 expression have significantly higher immune infiltration and improved response to therapeutics impacting cancer immunity upstream or downstream of the cGAMP-STING pathway, like PARP inhibitors and anti-PD1. Altogether, selective inhibition of ENPP1's cGAMP hydrolase activity alleviates an innate immune checkpoint to boost cancer immunity and is therefore a promising therapeutic approach against breast cancer that may synergize with other cancer immunotherapies.

ENPP1’s regulation of extracellular cGAMP is a ubiquitous mechanism of attenuating STING signaling

Identification of extracellular membrane protein ENPP3 as a major cGAMP hydrolase, cementing cGAMP’s role as an immunotransmitter

Identification of extracellular membrane protein ENPP3 as a major cGAMP hydrolase, cementing cGAMP's role as an immunotransmitter

Identification of the extracellular membrane protein ENPP3 as a major cGAMP hydrolase and innate immune checkpoint

Lysosomal Control of the Cgas-Sting Signaling.

Tumor Exosomal ENPP1 Hydrolyzes cGAMP to Inhibit cGAS-STING Signaling

ENPP1 is an innate immune checkpoint of the anticancer cGAMP-STING pathway

ENPP1 is an innate immune checkpoint of the anticancer cGAMP-STING pathway in breast cancer

Cellular functions of cGAS-STING signaling

Distinct Dynamical and Conformational Features of Human STING in Response to 2'3'-cGAMP and c-di-GMP.

A Novel Transcript Isoform of STING That Sequesters Cgamp and Dominantly Inhibits Innate Nucleic Acid Sensing

Targeting ENPP1 for cancer immunotherapy: Killing two birds with one stone

Current understanding of the cGAS-STING signaling pathway: Structure, regulatory mechanisms, and related diseases

Post-Translational Modifications of cGAS-STING: A Critical Switch for Immune Regulation

STEEP mediates STING ER exit and activation of signaling

Metastasis and Immune Evasion from Extracellular cGAMP Hydrolysis

IUPHAR ECR review: The cGAS-STING pathway: Novel functions beyond innate immune and emerging therapeutic opportunities

Function and regulation of cGAS-STING signaling in infectious diseases

Stimulating STING for cancer therapy: Taking the extracellular route

cGAMP-activated cGAS–STING signaling: its bacterial origins and evolutionary adaptation by metazoans

cGAS-cGAMP-STING: The three musketeers of cytosolic DNA sensing and signaling.